Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,427
Out of 5,044 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $124.43 | -3.56% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $82.69 | +57.21% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $73.98 | +48.69% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.13 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $68.18 | -54.17% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $22.25 | +57.30% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $128.12 | +130.25% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $53.34 | +70.60% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $55.88 | -51.68% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $316.17 | -78.81% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $124.43
Upside: -3.56%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $82.69
Upside: +57.21%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $73.98
Upside: +48.69%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.13
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $68.18
Upside: -54.17%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $22.25
Upside: +57.30%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $128.12
Upside: +130.25%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $53.34
Upside: +70.60%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $55.88
Upside: -51.68%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $316.17
Upside: -78.81%